发布求助
文献互助 智能选刊 最新文献

Correction: THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer

IF 27.7 1区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
Molecular Cancer Pub Date : 2025-06-26 DOI:10.1186/s12943-025-02388-6
Xing Zhou, Jiashu Han, Anning Zuo, Yuhao Ba, Shutong Liu, Hui Xu, Yuyuan Zhang, Siyuan Weng, Zhaokai Zhou, Long Liu, Peng Luo, Quan Cheng, Chuhan Zhang, Yukang Chen, Dan Shan, Benyu Liu, Shuaixi Yang, Xinwei Han, Jinhai Deng, Zaoqu Liu
{"title":"Correction: THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer","authors":"Xing Zhou, Jiashu Han, Anning Zuo, Yuhao Ba, Shutong Liu, Hui Xu, Yuyuan Zhang, Siyuan Weng, Zhaokai Zhou, Long Liu, Peng Luo, Quan Cheng, Chuhan Zhang, Yukang Chen, Dan Shan, Benyu Liu, Shuaixi Yang, Xinwei Han, Jinhai Deng, Zaoqu Liu","doi":"10.1186/s12943-025-02388-6","DOIUrl":null,"url":null,"abstract":"<p><b>Correction: Mol Cancer 23, 282 (2024)</b></p><p><b>https://doi.org/10.1186/s12943-024-02180-y</b></p><p>Following the publication of the original article [1], the authors reported that they identified an inadvertent duplication of images labeled GDSC and CTRP in the Fig. 2O, and wish to formally request an erratum to rectify this issue. In the correct Fig. 2, they have replaced the correct Fig. 2O. They are confident that the inadvertent panel duplication did not have any effect on their analyses or on any conclusions drawn from the paper, and they apologize for the error.</p><p>Incorrect Fig. 2:</p><figure><picture><source srcset=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12943-025-02388-6/MediaObjects/12943_2025_2388_Figa_HTML.png?as=webp\" type=\"image/webp\"/><img alt=\"figure a\" aria-describedby=\"Figa\" height=\"805\" loading=\"lazy\" src=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12943-025-02388-6/MediaObjects/12943_2025_2388_Figa_HTML.png\" width=\"685\"/></picture></figure><p>Correct Fig. 2:</p><figure><picture><source srcset=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12943-025-02388-6/MediaObjects/12943_2025_2388_Figb_HTML.png?as=webp\" type=\"image/webp\"/><img alt=\"figure b\" aria-describedby=\"Figb\" height=\"807\" loading=\"lazy\" src=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12943-025-02388-6/MediaObjects/12943_2025_2388_Figb_HTML.png\" width=\"685\"/></picture></figure><ol data-track-component=\"outbound reference\" data-track-context=\"references section\"><li data-counter=\"1.\"><p>Zhou X, Han J, Zuo A, et al. THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer. Mol Cancer. 2024;23:282. https://doi.org/10.1186/s12943-024-02180-y.</p><p>Article CAS PubMed PubMed Central Google Scholar </p></li></ol><p>Download references<svg aria-hidden=\"true\" focusable=\"false\" height=\"16\" role=\"img\" width=\"16\"><use xlink:href=\"#icon-eds-i-download-medium\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"></use></svg></p><span>Author notes</span><ol><li><p>Xing Zhou, Jiashu Han, Anning Zuo, Yuhao Ba and Shutong Liu contributed equally to this work and share first authorship.</p></li></ol><h3>Authors and Affiliations</h3><ol><li><p>Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China</p><p>Xing Zhou, Anning Zuo, Yuhao Ba, Shutong Liu, Hui Xu, Yuyuan Zhang, Siyuan Weng, Yukang Chen, Xinwei Han &amp; Zaoqu Liu</p></li><li><p>Interventional Institute of Zhengzhou University, Zhengzhou, Henan, 450052, China</p><p>Xing Zhou, Xinwei Han &amp; Zaoqu Liu</p></li><li><p>Interventional Treatment and Clinical Research Center of Henan Province, Zhengzhou, Henan, 450052, China</p><p>Xing Zhou, Xinwei Han &amp; Zaoqu Liu</p></li><li><p>Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China</p><p>Xing Zhou</p></li><li><p>Department of General Surgery, Peking Union Medical College Hospital, Beijing, 100020, China</p><p>Jiashu Han</p></li><li><p>Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China</p><p>Zhaokai Zhou</p></li><li><p>Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, 710061, China</p><p>Long Liu</p></li><li><p>Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China</p><p>Peng Luo</p></li><li><p>Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China</p><p>Quan Cheng</p></li><li><p>Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China</p><p>Chuhan Zhang</p></li><li><p>Clinical Science Institute, University Hospital Galway, Galway, Ireland</p><p>Dan Shan</p></li><li><p>Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China</p><p>Benyu Liu</p></li><li><p>Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China</p><p>Shuaixi Yang</p></li><li><p>Richard Dimbleby Department of Cancer Research, Comprehensive Cancer Centre, Kings College London, London, UK</p><p>Jinhai Deng</p></li><li><p>Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China</p><p>Zaoqu Liu</p></li></ol><span>Authors</span><ol><li><span>Xing Zhou</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Jiashu Han</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Anning Zuo</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Yuhao Ba</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Shutong Liu</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Hui Xu</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Yuyuan Zhang</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Siyuan Weng</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Zhaokai Zhou</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Long Liu</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Peng Luo</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Quan Cheng</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Chuhan Zhang</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Yukang Chen</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Dan Shan</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Benyu Liu</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Shuaixi Yang</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Xinwei Han</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Jinhai Deng</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Zaoqu Liu</span>View author publications<p><span>Search author on:</span><span>PubMed<span> </span>Google Scholar</span></p></li></ol><h3>Corresponding authors</h3><p>Correspondence to Xinwei Han, Jinhai Deng or Zaoqu Liu.</p><h3>Publisher’s note</h3><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p><p><b>Open Access</b> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.</p>\n<p>Reprints and permissions</p><img alt=\"Check for updates. Verify currency and authenticity via CrossMark\" height=\"81\" loading=\"lazy\" src=\"data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>\" width=\"57\"/><h3>Cite this article</h3><p>Zhou, X., Han, J., Zuo, A. <i>et al.</i> Correction: THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer. <i>Mol Cancer</i> <b>24</b>, 184 (2025). https://doi.org/10.1186/s12943-025-02388-6</p><p>Download citation<svg aria-hidden=\"true\" focusable=\"false\" height=\"16\" role=\"img\" width=\"16\"><use xlink:href=\"#icon-eds-i-download-medium\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"></use></svg></p><ul data-test=\"publication-history\"><li><p>Published<span>: </span><span><time datetime=\"2025-06-26\">26 June 2025</time></span></p></li><li><p>DOI</abbr><span>: </span><span>https://doi.org/10.1186/s12943-025-02388-6</span></p></li></ul><h3>Share this article</h3><p>Anyone you share the following link with will be able to read this content:</p><button data-track=\"click\" data-track-action=\"get shareable link\" data-track-external=\"\" data-track-label=\"button\" type=\"button\">Get shareable link</button><p>Sorry, a shareable link is not currently available for this article.</p><p data-track=\"click\" data-track-action=\"select share url\" data-track-label=\"button\"></p><button data-track=\"click\" data-track-action=\"copy share url\" data-track-external=\"\" data-track-label=\"button\" type=\"button\">Copy to clipboard</button><p> Provided by the Springer Nature SharedIt content-sharing initiative </p>","PeriodicalId":19000,"journal":{"name":"Molecular Cancer","volume":"648 1","pages":""},"PeriodicalIF":27.7000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12943-025-02388-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Correction: Mol Cancer 23, 282 (2024)

https://doi.org/10.1186/s12943-024-02180-y

Following the publication of the original article [1], the authors reported that they identified an inadvertent duplication of images labeled GDSC and CTRP in the Fig. 2O, and wish to formally request an erratum to rectify this issue. In the correct Fig. 2, they have replaced the correct Fig. 2O. They are confident that the inadvertent panel duplication did not have any effect on their analyses or on any conclusions drawn from the paper, and they apologize for the error.

Incorrect Fig. 2:

Abstract Image

Correct Fig. 2:

Abstract Image

  1. Zhou X, Han J, Zuo A, et al. THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer. Mol Cancer. 2024;23:282. https://doi.org/10.1186/s12943-024-02180-y.

    Article CAS PubMed PubMed Central Google Scholar

Download references

Author notes

  1. Xing Zhou, Jiashu Han, Anning Zuo, Yuhao Ba and Shutong Liu contributed equally to this work and share first authorship.

Authors and Affiliations

  1. Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China

    Xing Zhou, Anning Zuo, Yuhao Ba, Shutong Liu, Hui Xu, Yuyuan Zhang, Siyuan Weng, Yukang Chen, Xinwei Han & Zaoqu Liu

  2. Interventional Institute of Zhengzhou University, Zhengzhou, Henan, 450052, China

    Xing Zhou, Xinwei Han & Zaoqu Liu

  3. Interventional Treatment and Clinical Research Center of Henan Province, Zhengzhou, Henan, 450052, China

    Xing Zhou, Xinwei Han & Zaoqu Liu

  4. Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China

    Xing Zhou

  5. Department of General Surgery, Peking Union Medical College Hospital, Beijing, 100020, China

    Jiashu Han

  6. Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China

    Zhaokai Zhou

  7. Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, 710061, China

    Long Liu

  8. Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China

    Peng Luo

  9. Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China

    Quan Cheng

  10. Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China

    Chuhan Zhang

  11. Clinical Science Institute, University Hospital Galway, Galway, Ireland

    Dan Shan

  12. Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China

    Benyu Liu

  13. Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China

    Shuaixi Yang

  14. Richard Dimbleby Department of Cancer Research, Comprehensive Cancer Centre, Kings College London, London, UK

    Jinhai Deng

  15. Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China

    Zaoqu Liu

Authors
  1. Xing ZhouView author publications

    Search author on:PubMed Google Scholar

  2. Jiashu HanView author publications

    Search author on:PubMed Google Scholar

  3. Anning ZuoView author publications

    Search author on:PubMed Google Scholar

  4. Yuhao BaView author publications

    Search author on:PubMed Google Scholar

  5. Shutong LiuView author publications

    Search author on:PubMed Google Scholar

  6. Hui XuView author publications

    Search author on:PubMed Google Scholar

  7. Yuyuan ZhangView author publications

    Search author on:PubMed Google Scholar

  8. Siyuan WengView author publications

    Search author on:PubMed Google Scholar

  9. Zhaokai ZhouView author publications

    Search author on:PubMed Google Scholar

  10. Long LiuView author publications

    Search author on:PubMed Google Scholar

  11. Peng LuoView author publications

    Search author on:PubMed Google Scholar

  12. Quan ChengView author publications

    Search author on:PubMed Google Scholar

  13. Chuhan ZhangView author publications

    Search author on:PubMed Google Scholar

  14. Yukang ChenView author publications

    Search author on:PubMed Google Scholar

  15. Dan ShanView author publications

    Search author on:PubMed Google Scholar

  16. Benyu LiuView author publications

    Search author on:PubMed Google Scholar

  17. Shuaixi YangView author publications

    Search author on:PubMed Google Scholar

  18. Xinwei HanView author publications

    Search author on:PubMed Google Scholar

  19. Jinhai DengView author publications

    Search author on:PubMed Google Scholar

  20. Zaoqu LiuView author publications

    Search author on:PubMed Google Scholar

Corresponding authors

Correspondence to Xinwei Han, Jinhai Deng or Zaoqu Liu.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

Abstract Image

Cite this article

Zhou, X., Han, J., Zuo, A. et al. Correction: THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer. Mol Cancer 24, 184 (2025). https://doi.org/10.1186/s12943-025-02388-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12943-025-02388-6

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

分享
查看原文 本刊更多论文
更正：THBS2 +癌症相关成纤维细胞通过col8a1介导的PI3K/AKT激活在结直肠癌中促进EMT导致奥沙利铂耐药
更正：Mol Cancer 23,282 (2024)https://doi.org/10.1186/s12943-024-02180-yFollowing在原始文章[1]发表后，作者报告称他们在图20中发现了标记为GDSC和CTRP的图像的无意重复，并希望正式要求更正此问题。在正确的图2中，他们已经取代了正确的图20。他们确信，无意的小组重复对他们的分析或从论文中得出的任何结论没有任何影响，他们为错误道歉。不正确图2：正确图2：周旭，韩杰，左阿，等。THBS2 +癌相关成纤维细胞通过col8a1介导的PI3K/AKT激活在结直肠癌中促进EMT导致奥沙利铂耐药。巨蟹座。2024;23:282。https://doi.org/10.1186/s12943-024-02180-y.Article CAS PubMed PubMed Central谷歌学者下载参考文献作者说明周星、韩嘉舒、左安宁、巴雨浩、刘叔同对本文贡献相同，并共享第一作者。郑州大学第一附属医院介入放射科，河南郑州450052周星，左安宁，巴玉豪，刘淑彤，徐辉，张玉元，翁思源，陈玉康，韩新伟等；郑州大学干预研究所，河南郑州450052周星韩新伟河南省介入治疗与临床研究中心，河南郑州，450052刘枣曲郑州大学第一附属医院小儿外科，河南郑州，450052，中国周兴，北京协和医院普通外科，北京，100020，中国韩嘉舒，郑州大学第一附属医院泌尿外科，河南郑州，450052，中国周兆凯，西安交通大学第一附属医院肝胆外科，陕西西安，710061，刘国龙广州南方医科大学珠江医院肿瘤科，罗国鹏湖南长沙中南大学湘雅医院神经外科，湖南长沙410008，程国泉郑州大学第一附属医院肿瘤科，河南郑州450052，爱尔兰戈尔韦戈尔韦大学附属医院张楚汉临床科学研究所，丹·山天健先进生物医学实验室，郑州市郑州大学医学科学院刘本宇郑州市郑州大学第一附属医院结直肠外科杨淮西英国伦敦国王学院癌症综合中心肿瘤研究部邓金海中国医学科学院北京协和医学院基础医学研究所100730ChinaZaoqu liu authorszhou xing查看作者出版物搜索作者on:PubMed谷歌ScholarJiashu hanjiashu查看作者出版物搜索作者on:PubMed谷歌scholar静谧左ning查看作者出版物搜索作者on:PubMed谷歌ScholarYuhao BaView作者出版物搜索作者on:PubMed谷歌scholarshu桐刘淑彤查看作者出版物搜索作者on:PubMed谷歌ScholarHui徐晖查看作者出版物搜索作者on:PubMed谷歌ScholarYuyuan zhangyuyuan查看作者出版物搜索作者on:PubMed谷歌ScholarSiyuan wensiyuan查看作者出版物搜索作者on:PubMed谷歌ScholarZhaokai周兆凯查看作者出版物搜索作者on:PubMed谷歌ScholarLong刘龙查看作者出版物搜索作者on:PubMed谷歌ScholarPeng罗鹏查看作者出版物搜索作者on:PubMed谷歌ScholarQuan chengquan查看作者出版物搜索作者on:PubMed谷歌scholarhan zhang查看作者出版物搜索作者on:PubMed谷歌ScholarYukang陈玉康查看作者出版物搜索作者on:PubMed谷歌ScholarDan shandan查看作者publications搜索作者on:PubMed谷歌ScholarBenyu liubenyu查看作者publications搜索作者on:PubMed谷歌ScholarShuaixi杨帅希查看作者publications搜索作者on:PubMed谷歌ScholarXinwei韩鑫伟查看作者出版物搜索作者on:PubMed谷歌ScholarJinhai邓金海查看作者出版物搜索作者on:PubMed谷歌ScholarZaoqu liu查看作者出版物搜索作者on:PubMed谷歌ScholarZaoqu韩鑫伟，邓金海，刘灶渠。出版方声明：对于已出版地图的管辖权要求和机构关系，普林格·自然保持中立。开放获取本文遵循知识共享署名-非商业性-禁止衍生协议4。 国际许可，允许以任何媒介或格式进行任何非商业使用、共享、分发和复制，只要您适当地注明原作者和来源，提供知识共享许可的链接，并注明您是否修改了许可的材料。根据本许可协议，您无权分享源自本文或其部分内容的改编材料。本文中的图像或其他第三方材料包含在文章的知识共享许可协议中，除非在材料的署名中另有说明。如果材料未包含在文章的知识共享许可中，并且您的预期用途不被法律法规允许或超过允许的用途，您将需要直接获得版权所有者的许可。要查看本许可协议的副本，请访问http://creativecommons.org/licenses/by-nc-nd/4.0/.Reprints和permissionsCite。更正：THBS2 +癌症相关成纤维细胞通过col8a1介导的PI3K/AKT激活在结直肠癌中促进EMT导致奥沙利铂耐药。癌症学报，24,184（2025）。https://doi.org/10.1186/s12943-025-02388-6Download citationpublishing: 26 June 2025DOI: https://doi.org/10.1186/s12943-025-02388-6Share这篇文章任何你与以下链接分享的人都可以阅读到这篇文章：获取可共享链接对不起，这篇文章目前没有可共享的链接。复制到剪贴板由施普林格自然共享内容倡议提供
本文章由计算机程序翻译，如有差异，请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular Cancer
Molecular Cancer 医学-生化与分子生物学
CiteScore
54.90
自引率
2.70%
发文量
224
审稿时长
2 months
期刊介绍： Molecular Cancer is a platform that encourages the exchange of ideas and discoveries in the field of cancer research, particularly focusing on the molecular aspects. Our goal is to facilitate discussions and provide insights into various areas of cancer and related biomedical science. We welcome articles from basic, translational, and clinical research that contribute to the advancement of understanding, prevention, diagnosis, and treatment of cancer. The scope of topics covered in Molecular Cancer is diverse and inclusive. These include, but are not limited to, cell and tumor biology, angiogenesis, utilizing animal models, understanding metastasis, exploring cancer antigens and the immune response, investigating cellular signaling and molecular biology, examining epidemiology, genetic and molecular profiling of cancer, identifying molecular targets, studying cancer stem cells, exploring DNA damage and repair mechanisms, analyzing cell cycle regulation, investigating apoptosis, exploring molecular virology, and evaluating vaccine and antibody-based cancer therapies. Molecular Cancer serves as an important platform for sharing exciting discoveries in cancer-related research. It offers an unparalleled opportunity to communicate information to both specialists and the general public. The online presence of Molecular Cancer enables immediate publication of accepted articles and facilitates the presentation of large datasets and supplementary information. This ensures that new research is efficiently and rapidly disseminated to the scientific community.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信